Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss
de Bono, Johann S, De Giorgi, Ugo, Rodrigues, Daniel Nava, Massard, Christophe, Bracarda, Sergio, Font, Albert, Arranz Arija, Jose Angel, Shih, Kent C, Radavoi, George Daniel, Xu, Na, Chan, Wai Y, Ma, Han, Gendreau, Steven, Riisnaes, Ruth, Patel, Premal H, Maslyar, Daniel J, Jinga, Viorel
Published in Clinical cancer research (01.02.2019)
Published in Clinical cancer research (01.02.2019)
Get full text
Journal Article
Ipatasertib plus paclitaxel versus placebo plus paclitaxel as first-line therapy for metastatic triple-negative breast cancer (LOTUS): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial
Kim, Sung-Bae, Dent, Rebecca, Im, Seock-Ah, Espié, Marc, Blau, Sibel, Tan, Antoinette R, Isakoff, Steven J, Oliveira, Mafalda, Saura, Cristina, Wongchenko, Matthew J, Kapp, Amy V, Chan, Wai Y, Singel, Stina M, Maslyar, Daniel J, Baselga, José, Kim, Sung-Bae, Lee, Keun Seok, Im, Seock-Ah, Espié, Marc, Wang, Hwei-Chung, Blau, Sibel, Dent, Rebecca, Tan, Antoinette, Sohn, Joo Hyuk, De Laurentiis, Michelino, Estevez, Laura Garcia, Huang, Chiun-Sheng, Romieu, Gilles, Velez, Michel, Villanueva, Rafael, Conte, Pier Franco, Dakhil, Shaker, Debled, Marc, Martin, Antonio Gonzalez, Hurvitz, Sara, Kim, Jee Hyun, Levy, Christelle, Oliveira, Mafalda, Rovira, Pedro Sanchez, Seo, Jae Hong, Valero, Vicente, Vidal, Gregory, Wong, Andrea, Allison, Mary Ann K, Figlin, Robert, Chan, David, Chen, Shin-Cheh, Chen, Yen-Hsun, Cobleigh, Melody, De Braud, Filippo, Dirix, Luc, Hansen, Vincent, Bessard, Anne Hardy, Iannotti, Nicholas, Isakoff, Steven, Lawler, William, Montaño, Alvaro, Salkini, Mohamad, Seigel, Leonard
Published in The lancet oncology (01.10.2017)
Published in The lancet oncology (01.10.2017)
Get full text
Journal Article
A First in Human Phase 1 Study of CG0070, a GM-CSF Expressing Oncolytic Adenovirus, for the Treatment of Nonmuscle Invasive Bladder Cancer
Burke, James M, Lamm, Donald L, Meng, Maxwell V, Nemunaitis, John J, Stephenson, Joseph J, Arseneau, James C, Aimi, Junko, Lerner, Seth, Yeung, Alex W, Kazarian, Troy, Maslyar, Daniel J, McKiernan, James M
Published in The Journal of urology (01.12.2012)
Published in The Journal of urology (01.12.2012)
Get full text
Journal Article
Phase I Study of DSTP3086S, an Antibody-Drug Conjugate Targeting Six-Transmembrane Epithelial Antigen of Prostate 1, in Metastatic Castration-Resistant Prostate Cancer
Danila, Daniel C, Szmulewitz, Russell Z, Vaishampayan, Ulka, Higano, Celestia S, Baron, Ari D, Gilbert, Houston N, Brunstein, Flavia, Milojic-Blair, Marija, Wang, Bei, Kabbarah, Omar, Mamounas, Michael, Fine, Bernard M, Maslyar, Daniel J, Ungewickell, Alexander, Scher, Howard I
Published in Journal of clinical oncology (20.12.2019)
Published in Journal of clinical oncology (20.12.2019)
Get full text
Journal Article
Phase I Study of DMOT4039A, an Antibody-Drug Conjugate Targeting Mesothelin, in Patients with Unresectable Pancreatic or Platinum-Resistant Ovarian Cancer
Weekes, Colin D, Lamberts, Laetitia E, Borad, Mitesh J, Voortman, Johannes, McWilliams, Robert R, Diamond, Jennifer R, de Vries, Elisabeth G E, Verheul, Henk M, Lieu, Christopher H, Kim, George P, Wang, Yulei, Scales, Suzie J, Samineni, Divya, Brunstein, Flavia, Choi, YounJeong, Maslyar, Daniel J, Colon-Otero, Gerardo
Published in Molecular cancer therapeutics (01.03.2016)
Published in Molecular cancer therapeutics (01.03.2016)
Get full text
Journal Article
Phase 1 study of latozinemab in progranulin‐associated frontotemporal dementia
Ward, Michael, Carter, Lawrence P., Huang, Julie Y., Maslyar, Daniel, Budda, Balasubrahmanyam, Paul, Robert, Rosenthal, Arnon
Published in Alzheimer's & dementia : translational research & clinical interventions (01.01.2024)
Published in Alzheimer's & dementia : translational research & clinical interventions (01.01.2024)
Get full text
Journal Article
Granulocyte-macrophage colony-stimulating factor (GM-CSF)–secreting cellular immunotherapy in combination with autologous stem cell transplantation (ASCT) as postremission therapy for acute myeloid leukemia (AML)
Borrello, Ivan M., Levitsky, Hyam I., Stock, Wendy, Sher, Dorie, Qin, Lu, DeAngelo, Daniel J., Alyea, Edwin P., Stone, Richard M., Damon, Lloyd E., Linker, Charles A., Maslyar, Daniel J., Hege, Kristen M.
Published in Blood (27.08.2009)
Published in Blood (27.08.2009)
Get full text
Journal Article
Small-Molecule Antagonists of Myc/Max Dimerization Inhibit Myc-Induced Transformation of Chicken Embryo Fibroblasts
Berg, Thorsten, Cohen, Steven B., Desharnais, Joel, Sonderegger, Corinna, Maslyar, Daniel J., Goldberg, Joel, Boger, Dale L., Vogt, Peter K.
Published in Proceedings of the National Academy of Sciences - PNAS (19.03.2002)
Published in Proceedings of the National Academy of Sciences - PNAS (19.03.2002)
Get full text
Journal Article
Overall survival (OS) update of the double-blind placebo (PBO)-controlled randomized phase 2 LOTUS trial of first-line ipatasertib (IPAT) + paclitaxel (PAC) for locally advanced/metastatic triple-negative breast cancer (mTNBC)
Dent, Rebecca, Im, Seock-Ah, Espie, Marc, Blau, Sibel, Tan, Antoinette R., Isakoff, Steven J., Oliveira, Mafalda, Saura, Cristina, Wongchenko, Matthew, Kapp, Amy V., Chan, Wai Y., Singel, Stina M., Maslyar, Daniel J., Baselga, Jose, Kim, Sung-Bae
Published in Journal of clinical oncology (20.05.2018)
Published in Journal of clinical oncology (20.05.2018)
Get full text
Journal Article
AL008 Enhances Myeloid Antitumor Function by Inhibiting SIRPα Signaling and Activating Fc Receptors
Yang, Jingping, Deresa, Isaiah, Ho, Wei-Hsien, Long, Hua, Maslyar, Daniel, Rosenthal, Arnon, Liang, Spencer C, Pincetic, Andrew
Published in The Journal of immunology (1950) (15.01.2023)
Published in The Journal of immunology (1950) (15.01.2023)
Get full text
Journal Article
Phase Ia Study of Anti-NaPi2b Antibody-Drug Conjugate Lifastuzumab Vedotin DNIB0600A in Patients with Non-Small Cell Lung Cancer and Platinum-Resistant Ovarian Cancer
Gerber, David E, Infante, Jeffrey R, Gordon, Michael S, Goldberg, Sarah B, Martín, Miguel, Felip, Enriqueta, Martinez Garcia, Maria, Schiller, Joan H, Spigel, David R, Cordova, Julie, Westcott, Valerie, Wang, Yulei, Shames, David S, Choi, YounJeong, Kahn, Robert, Dere, Randall C, Samineni, Divya, Xu, Jian, Lin, Kedan, Wood, Katie, Royer-Joo, Stephanie, Lemahieu, Vanessa, Schuth, Eva, Vaze, Anjali, Maslyar, Daniel, Humke, Eric W, Burris, 3rd, Howard A
Published in Clinical cancer research (15.01.2020)
Published in Clinical cancer research (15.01.2020)
Get full text
Journal Article
Phase 1b study of anti-NaPi2b antibody-drug conjugate lifastuzumab vedotin (DNIB0600A) in patients with platinum-sensitive recurrent ovarian cancer
Moore, Kathleen N., Birrer, Michael J., Marsters, Jim, Wang, Yulei, Choi, YounJeong, Royer-Joo, Stephanie, Lemahieu, Vanessa, Armstrong, Katy, Cordova, Julie, Samineni, Divya, Schuth, Eva, Vaze, Anjali, Maslyar, Daniel, Humke, Eric W., Hamilton, Erika P., Liu, Joyce F.
Published in Gynecologic oncology (01.09.2020)
Published in Gynecologic oncology (01.09.2020)
Get full text
Journal Article
ImmunoPET with Anti-Mesothelin Antibody in Patients with Pancreatic and Ovarian Cancer before Anti-Mesothelin Antibody-Drug Conjugate Treatment
Lamberts, Laetitia E, Menke-van der Houven van Oordt, Catharina W, ter Weele, Eva J, Bensch, Frederike, Smeenk, Michiel M, Voortman, Johannes, Hoekstra, Otto S, Williams, Simon P, Fine, Bernard M, Maslyar, Daniel, de Jong, Johan R, Gietema, Jourik A, Schröder, Carolien P, Bongaerts, Alphons H H, Lub-de Hooge, Marjolijn N, Verheul, Henk M W, Sanabria Bohorquez, Sandra M, Glaudemans, Andor W J M, de Vries, Elisabeth G E
Published in Clinical cancer research (01.04.2016)
Published in Clinical cancer research (01.04.2016)
Get full text
Journal Article
Abstract 613: AL009 is a multi-Siglec inhibitor engineered to bind myeloid cells that enhances innate and adaptive immunity to cancer
Nalle, Sam, Lam, Helen, Barner, Cheryl, Long, Hua, Liang, Spencer, Rosenthal, Arnon, Maslyar, Daniel
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Published in Cancer research (Chicago, Ill.) (15.06.2022)
Get full text
Journal Article
LOTUS (NCT02162719): A double-blind placebo (PBO)-controlled randomized phase II trial of first-line ipatasertib (IPAT) + paclitaxel (P) for metastatic triple-negative breast cancer (TNBC)
Dent, Rebecca Alexandra, Kim, Sung-Bae, Im, Seock-Ah, Espie, Marc, Blau, Sibel, Tan, Antoinette R., Isakoff, Steven, Oliveira, Mafalda, Saura, Cristina, Wongchenko, Matthew, Kapp, Amy V., Chan, Wai Y., Singel, Stina M., Maslyar, Daniel J., Baselga, Jose
Published in Journal of clinical oncology (20.05.2017)
Published in Journal of clinical oncology (20.05.2017)
Get full text
Journal Article
Abstract CT041: Primary results from FAIRLANE (NCT02301988), a double-blind placebo (PBO)-controlled randomized phase II trial of neoadjuvant ipatasertib (IPAT) + paclitaxel (PAC) for early triple-negative breast cancer (eTNBC)
Oliveira, Mafalda, Saura, Cristina, Calvo, Isabel, Andersen, Jay, Coelho, José Luis Passos, Gil, Miguel Gil, Bermejo, Begoña, Patt, Debra A., Ciruelos, Eva, Singel, Stina M., Maslyar, Daniel J., Wongchenko, Matthew, Chan, Wai Y., Kapp, Amy V., Peña, Lorena de la, Baselga, José, Isakoff, Steven J.
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Published in Cancer research (Chicago, Ill.) (01.07.2018)
Get full text
Journal Article
NGS, RNA-Seq, TIL, and PTEN analyses in prostate cancer specimens from patients enrolled in the study of the Akt inhibitor ipatasertib (Ipat) combined with abiraterone acetate (AA)
Zhang, Liangxuan, Koeppen, Hartmut, Maslyar, Daniel J., Fillos, Dimitri, Xu, Na, Chan, Wai Y., Font Pous, Albert, Jinga, Viorel, Massard, Christophe, Bracarda, Sergio, Radavoi, George Daniel, De Giorgi, Ugo, Arranz Arija, Jose Angel, Riisnaes, Ruth, Nava Rodrigues, Daniel, De Bono, Johann S., Gendreau, Steven
Published in Journal of clinical oncology (20.02.2018)
Published in Journal of clinical oncology (20.02.2018)
Get full text
Journal Article
Exposure–Response‐Based Product Profile–Driven Clinical Utility Index for Ipatasertib Dose Selection in Prostate Cancer
Zhu, Rui, Poland, Bill, Wada, Russ, Liu, Qi, Musib, Luna, Maslyar, Daniel, Cho, Eunpi, Yu, Wei, Ma, Han, Jin, Jin Yan, Budha, Nageshwar
Published in CPT: pharmacometrics and systems pharmacology (01.04.2019)
Published in CPT: pharmacometrics and systems pharmacology (01.04.2019)
Get full text
Journal Article